Suppression/NN
of/IN
human/JJ
anti-porcine/JJ
T-cell/NN
immune/JJ
responses/NNS
by/IN
major/JJ
histocompatibility/NN
complex/NN
class/NN
II/CD
transactivator/NN
constructs/NNS
lacking/VBG
the/DT
amino/NN
terminal/JJ
domain/NN
./.

BACKGROUND/NN
:/:
The/DT
class/NN
II/CD
transactivator/NN
(/(
CIITA/NN
)/)
is/VBZ
a/DT
bi-/JJ
or/CC
multifunctional/JJ
domain/NN
protein/NN
that/WDT
acts/VBZ
as/IN
a/DT
transcriptional/JJ
activator/NN
and/CC
plays/VBZ
a/DT
critical/JJ
role/NN
in/IN
the/DT
expression/NN
of/IN
MHC/NN
class/NN
II/CD
genes/NNS
./.
=====
We/PRP
have/VBP
previously/RB
demonstrated/VBN
that/IN
a/DT
mutated/VBN
form/NN
of/IN
the/DT
human/JJ
CIITA/NN
gene/NN
,/,
coding/VBG
for/IN
a/DT
protein/NN
lacking/VBG
the/DT
amino/NN
terminal/JJ
151/CD
amino/NN
acids/NNS
,/,
acts/VBZ
as/IN
a/DT
potent/JJ
dominant-negative/JJ
suppressor/NN
of/IN
HLA/NN
class/NN
II/CD
expression/NN
./.
=====
Porcine/NN
MHC/NN
class/NN
II/CD
antigens/NNS
are/VBP
potent/JJ
stimulators/NNS
of/IN
direct/JJ
T-cell/NN
recognition/NN
by/IN
human/JJ
CD4+/JJ
T/NN
cells/NNS
and/CC
are/VBP
,/,
therefore/RB
,/,
likely/JJ
to/TO
play/VB
an/DT
important/JJ
role/NN
in/IN
the/DT
rejection/NN
responses/NNS
to/TO
transgenic/JJ
pig/NN
donors/NNS
in/IN
clinical/JJ
xenotransplantation/NN
./.
=====
We/PRP
were/VBD
,/,
therefore/RB
,/,
interested/VBD
in/IN
examining/VBG
mutated/VBN
CIITA/NN
constructs/NNS
for/IN
their/PRP$
effect/NN
on/IN
porcine/NN
MHC/NN
class/NN
II/CD
expression/NN
./.
=====
METHODS/NNS
:/:
Stable/JJ
transfectants/NNS
of/IN
the/DT
porcine/NN
vascular/JJ
endothelial/JJ
cell/NN
line/NN
PIEC/NN
with/IN
mutated/VBN
CIITA/NN
constructs/NNS
were/VBD
tested/VBN
for/IN
SLA-DR/NN
and/CC
SLA-DQ/NN
induction/NN
by/IN
recombinant/JJ
porcine/NN
interferon-gamma/NN
./.
=====
Transient/JJ
transfectants/NNS
of/IN
the/DT
porcine/NN
B-cell/NN
line/NN
L23/NN
with/IN
the/DT
mutated/VBN
CIITA/NN
constructs/NNS
were/VBD
tested/VBN
for/IN
the/DT
suppression/NN
of/IN
constitutive/JJ
SLA-DR/NN
and/CC
SLA-DQ/NN
expression/NN
./.
=====
T-cell/NN
proliferation/NN
studies/NNS
were/VBD
performed/VBN
using/VBG
highly/RB
purified/VBN
human/JJ
CD4+/JJ
T/NN
cells/NNS
./.
=====
RESULTS/NNS
:/:
In/FW
preliminary/JJ
studies/NNS
,/,
we/PRP
demonstrated/VBD
that/IN
transfection/NN
of/IN
the/DT
PIEC/NN
line/NN
with/IN
full-length/JJ
human/JJ
CIITA/NN
constructs/NNS
resulted/VBD
in/IN
strong/JJ
expression/NN
of/IN
SLA-DR/NN
and/CC
SLA-DQ/NN
antigens/NNS
,/,
thus/RB
establishing/VBG
the/DT
cross-species/JJ
effectiveness/NN
of/IN
human/JJ
CIITA/NN
in/IN
the/DT
pig/NN
./.
=====
The/DT
mutated/VBN
human/JJ
CIITA/NN
constructs/NNS
were/VBD
,/,
therefore/RB
,/,
tested/VBN
in/IN
the/DT
pig/NN
./.
=====
PIEC/NN
clones/NNS
stably/RB
transfected/VBN
with/IN
one/CD
of/IN
these/DT
constructs/NNS
showed/VBD
up/RB
to/TO
99/CD
%/NN
suppression/NN
of/IN
SLA-DR/NN
and/CC
SLA-DQ/NN
antigen/NN
induction/NN
and/CC
marked/JJ
suppression/NN
of/IN
SLA-DRA/NN
mRNA/NN
induction/NN
./.
=====
Moreover/RB
,/,
transient/JJ
transfection/NN
of/IN
the/DT
porcine/NN
B-cell/NN
line/NN
L23/NN
showed/VBD
up/RB
to/TO
90/CD
%/NN
suppression/NN
of/IN
constitutive/JJ
SLA-DR/NN
and/CC
SLA-DQ/NN
antigen/NN
expression/NN
in/IN
5-8/CD
days/NNS
./.
=====
In/IN
functional/JJ
studies/NNS
,/,
interferon-gamma-stimulated/JJ
PIEC/NN
clones/NNS
transfected/VBN
with/IN
this/DT
mutated/VBN
CIITA/NN
construct/NN
failed/VBD
to/TO
stimulate/VB
purified/VBN
human/JJ
CD4+/JJ
T/NN
lymphocytes/NNS
./.
=====
CONCLUSION/NN
:/:
Mutated/JJ
human/JJ
CIITA/NN
constructs/NNS
are/VBP
potent/JJ
suppressors/NNS
of/IN
porcine/NN
MHC/NN
class/NN
II/CD
expression/NN
./.